Evaluation of pharmacokinetic and pharmacodynamic parameters of meropenem in critically ill patients with acute kidney disease.

Rezvan HassanpourShadi ZiaieFarzad KobarfardMehran KouchekMirmohammad MiriAzadeh Ahmadi KoomlehSeyedpouzhia ShojaeiSara SalarianElham PourheidarFatemeh NezaratMohammad Sistanizd

Published in: European journal of clinical pharmacology (2021)

The study protocol with registered retrospectively and approved on January 19, 2019, with the number of IRCT20160412027346N5.

Keyphrases

study protocol
randomized controlled trial
drug administration
clinical trial
gram negative
open label
double blind
placebo controlled
multidrug resistant